MedPath

Mivacurium

Generic Name
Mivacurium
Drug Type
Small Molecule
Chemical Formula
C58H80N2O14
CAS Number
133814-19-4
Unique Ingredient Identifier
77D66S9Q93

Overview

Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission.

Background

Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission.

Indication

For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

MIVACRON INJECTION 10 mg/5 ml
Manufacturer:GLAXOSMITHKLINE MANUFACTURING SPA, Aspen SVP
Form:INJECTION
Strength:10 mg/5 ml
Online:Yes
Approved: 1994/01/26
Approval:SIN07624P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath